BNET Industries
Last Fiscal Year Sales:$310.5M
- Private
- US
Dow Jones Description
Soft Contact Lenses Mfr
Board of Directors
Terrance H. GreggNumber of Employees 2,591
Contact Information
475 Eccles Ave
South San Francisco, California 94080-1902
(650) 583-1400
Peer Companies
NAICS Code Surgical Appliance and Supplies Manufacturing: 339113
Recent Events
-
Ocular Sciences Raises and Narrows Guidance
News & Analysis
Filter by
ocular sciences inc. - All News and Analysis
Contact Lens Maker Picks Albuquerque, N.M., for Expansion.
By Aaron Baca, Albuquerque Journal, N.M. Knight Ridder/Tribune Business News Jun. 6--ALBUQUERQUE, N.M.--It's Tuesday morning after Memorial Day and construction workers are putting the finishing touches on a concrete bench that neatly divides a prep room inside a work area at ...
Ocular Sciences, Inc.(OCLR) - Quantitative Valuation Report.
M2 PRESSWIRE-9 March 2003-Research and Markets: Ocular Sciences, Inc.OCLR - Quantitative Valuation ReportC1994-2003 M2 COMMUNICATIONS LTD RDATE:03082003 Company Name - Ocular Sciences, Inc. Now you, as an individual investor or investment professional, can have access to the same...
Ocular Sciences: Disposable Income.
Byline:Kiplinger Washington Editors Contact lens maker Ocular Sciences is finding out that making throw-away products is a handy way to generate revenue.Of its soft contact lens business, monthly and weekly disposable contacts account for 90% of sales. The company is also experimenting...
Ocular Sciences Inc. pursues lens scams. (News Review).(Brief Article)
Contact lens manufacturer Ocular Sciences Inc. OSI won the first round in its suit against JG Optical, a New York-based contact lens whole-saler, when the U.S. District Court for the Northern District of California denied JG Optical's motion to dismiss the complaint. ...
Ocular Sciences: The power of insight. (Biomedics Toric).(Brief Article)
DEAR COLLEAGUE, With so much challenge and change facing optometrists these days, a new product launch can get lost in the fray -- even a new product launch with a story as compelling as the Biomedics Toric's behind it. ...
Web Retailer to Drop OSI's Products. (News Review).(Go2Contacts.com; Ocular Sciences Inc.)(Brief Article)
Ocular Sciences Inc. has resolved its litigation with Go2Contacts.com. The Internet-based retailer has agreed to a court order that prohibits it from selling or advertising OSI's products or substituting OSI's lenses with those of competitors, and requires it to remove references to OSI and its products...
Ocular Sciences Reports 44% Third Quarter Revenue Growth and Net Income Growth of 28%
Business Editors CONCORD, Calif.--BUSINESS WIRE--Oct. 30, 2001 Ocular Sciences, Inc. (Nasdaq:OCLR) today reported its financial results for the third quarter ended September 30, 2001. Total revenue for the third quarter increased 44% to $68.9 million from $47.8 million in the comparable quarter of the previous year. Net income...
Ocular Sciences Announces Third Quarter 2001 Earnings Release Date and Conference Call
Business Editors CONCORD, Calif.--BUSINESS WIRE--Oct. 24, 2001 Ocular Sciences, Inc. (Nasdaq:OCLR) today announced that it will host a conference call and webcast on Tuesday, October 30, 2001 at 1:30 p.m. Pacific Daylight Time to discuss the Company's third quarter 2001 financial results and current corporate developments. The dial-in...
Ocular Sciences Appoints Stephen J. Fanning President and Chief Executive Officer
Business Editors CONCORD, Calif.--BUSINESS WIRE--Aug. 14, 2001 Ocular Sciences, Inc. (Nasdaq:OCLR) today announced the appointment of Stephen J. Fanning, 50, as President, Chief Executive Officer and member of the Board of Directors. Fanning joins Ocular from Johnson & Johnson (NYSE:JNJ), one of the world's largest manufacturers of healthcare...
Ocular Sciences Reports 43% Second Quarter Revenue Growth; EPS Grows 21% as U.S. Sales Climb 26% and Fully Diluted Shares Increase 3%
Business Editors CONCORD, Calif.--BUSINESS WIRE--Aug. 8, 2001 Ocular Sciences, Inc. (NASDAQ: OCLR) today reported its financial results for the second quarter ended June 30, 2001. Revenue for the second quarter increased 43% to a record $61.4 million, compared to revenue of $42.9 million in prior year's second quarter....
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Terrance H. Gregg | Board of Directors |
| William R. Grant | Board Member |
Array
| Organization | Position | Status |
|---|---|---|
| LMS Medical Systems Inc. | Board of Directors | Current |
| DexCom, Inc. | Board of Directors | Current |
| Vasogen, Inc. | Board of Directors | Current |
| Ocular Sciences, Inc. | Board of Directors | Current |
| Specialty Laboratories, Inc. | Board of Directors | Current |
| Amylin Pharmaceuticals, Inc. | Board of Directors | Current |
| Vasogen, Inc. | Chief Executive Officer | Former |
| Medtronic Minimed, Inc. | President | Former |
| University of Southern California | President | Former |
| Minimed, Inc. | President | Former |
| Southern California University | President | Former |
| Minimed, Inc. | Chief Operating Officer | Former |
| Minimed, Inc. | Executive Vice President, Operations | Former |
| Galen Partners | Special Ventures Partner | Former |
| Medtronic, Inc. | Senior Adviser | Former |
| Allergan, Inc. | Former | |
| Vasogen, Inc. | Chairman | Former |
| Colorado State University | Bachelor of Science Degree In Zoology | Former |
| Organization | Position | Status |
|---|---|---|
| LabOne, Inc. | Current | |
| First Responders Financial LLC | Board of Directors | Current |
| Quest Diagnostics Incorporated | Board of Directors | Current |
| Vasogen, Inc. | Board of Directors | Current |
| Massey Energy Company | Board of Directors | Current |
| Allergan, Inc. | Board Member | Current |
| Ocular Sciences, Inc. | Board Member | Current |
| MacKay-Shields Financial Corp. | President | Former |
| Smith Barney | President | Former |
| Galen Partners | Co-founder | Former |
| Advanced Medical Optics, Inc. | Chairman | Former |
| Vasogen, Inc. | Chairman of the Board | Former |
| MacKay-Shields Financial Corp. | Chairman | Former |
| Advanced Medical Optics, Inc. | Director | Former |
| Smith Barney | Vice-Chairman | Former |
| GlaxoSmithKline Plc | Director | Former |
| GlaxoSmithKline Plc | Vice Chairman | Former |
| Marion Laboratories | Investor | Former |
| American Hospital Supply Corporation | Investor | Former |
| SmithKline Beecham Corporation | Investor | Former |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes



